10-Q Filing

ARROWHEAD PHARMACEUTICALS, INC. CIK: 879407 Q3 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-036812`
Period End Date	20200630
Filing Date	20200805
Fiscal Year	2020
Fiscal Period	Q3
XBRL Instance	arwr-10q_20200630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 72 Income Statement 60 Cash Flow Statement 52 Stockholders Equity 31

Balance Sheet 72 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	145.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	95.51M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$219.32M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	102.25M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$221.80M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	102.25M	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$661.36K	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$21.69M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	95.51M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$3.32M	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$4.10M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.41M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.56M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$36.90M	USD	Point-in-time
Short term investments	`HeldToMaturitySecuritiesCurrent`	$67.71M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$315.23M	USD	Point-in-time
TOTAL CURRENT ASSETS	`AssetsCurrent`	$265.25M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$30.39M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$23.21M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$15.79M	USD	Point-in-time
Intangible assets, net	`FiniteLivedIntangibleAssetsNet`	$17.06M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$44.18M	USD	Point-in-time
Long term investments	`HeldToMaturitySecuritiesNoncurrent`	$177.53M	USD	Point-in-time
Right-of-use assets	`OperatingLeaseRightOfUseAsset`	$16.52M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$265.36K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$144.15K	USD	Point-in-time
TOTAL ASSETS	`Assets`	$555.73M	USD	Point-in-time
TOTAL ASSETS	`Assets`	$349.85M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$4.07M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.65M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$9.41M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$6.50M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$1.99M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$4.96M	USD	Point-in-time
Lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.01M	USD	Point-in-time
Deferred rent	`DeferredRentCreditCurrent`	$173.95K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$77.77M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$26.27M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$17.26K	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$16.56K	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$42.78M	USD	Point-in-time
TOTAL CURRENT LIABILITIES	`LiabilitiesCurrent`	$97.07M	USD	Point-in-time
Lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$20.36M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$3.70M	USD	Point-in-time
Deferred revenue, net of current portion	`ContractWithCustomerLiabilityNoncurrent`	$5.04M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$20.36M	USD	Point-in-time
TOTAL LONG-TERM LIABILITIES	`LiabilitiesNoncurrent`	$8.74M	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 7)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 102,250,872 and 95,506,271 shares issued and outstanding as of June 30, 2020 and September 30, 2019, respectively	`CommonStockValue`	$194.62K	USD	Point-in-time
Common stock, $0.001 par value; 145,000,000 shares authorized; 102,250,872 and 95,506,271 shares issued and outstanding as of June 30, 2020 and September 30, 2019, respectively	`CommonStockValue`	$187.88K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$948.53M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$664.09M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-391.62K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-175.22K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-455.41M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-419.29M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$244.59M	USD	Point-in-time
Total Arrowhead Pharmaceuticals, Inc. stockholders' equity	`StockholdersEquity`	$493.14M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-555.19K	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$492.59M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$493.56M	USD	Point-in-time
TOTAL STOCKHOLDERS EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$225.67M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$349.85M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS EQUITY	`LiabilitiesAndStockholdersEquity`	$555.73M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$80.36M	USD	3 Qtrs
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$42.70M	USD	1 Quarter
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$125.50M	USD	3 Qtrs
REVENUE	`RevenueFromContractWithCustomerExcludingAssessedTax`	$27.38M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$57.66M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$32.57M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$85.39M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost`	$19.29M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$16.29M	USD	3 Qtrs
General and administrative expenses	`GeneralAndAdministrativeExpense`	$10.75M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$4.81M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$38.01M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$43.32M	USD	1 Quarter
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$123.40M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$73.95M	USD	3 Qtrs
TOTAL OPERATING EXPENSES	`OperatingExpenses`	$24.10M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$51.55M	USD	3 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-15.95M	USD	1 Quarter
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$-43.04M	USD	3 Qtrs
OPERATING INCOME (LOSS)	`OperatingIncomeLoss`	$18.60M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$2.33M	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$4.72M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$6.92M	USD	3 Qtrs
Interest income (expense), net	`InterestIncomeExpenseNonoperatingNet`	$1.74M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$4.72M	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$1.74M	USD	1 Quarter
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$6.92M	USD	3 Qtrs
TOTAL OTHER INCOME (EXPENSE)	`NonoperatingIncomeExpense`	$2.33M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-36.12M	USD	3 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$56.27M	USD	3 Qtrs
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-13.61M	USD	1 Quarter
INCOME (LOSS) BEFORE INCOME TAXES	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$20.34M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$20.34M	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-36.12M	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$56.27M	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-13.61M	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.21	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$0.60	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - BASIC	`EarningsPerShareBasic`	$-0.36	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.21	USD	1 Quarter
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.36	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$0.58	USD	3 Qtrs
NET INCOME (LOSS) PER SHARE - DILUTED	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	94.94M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	101.84M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.36M	shares	3 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	100.18M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.88M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	97.81M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	100.18M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	101.84M	shares	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$216.41K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-81.51K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-31.17K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$453.89K	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$20.30M	USD	1 Quarter
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$56.19M	USD	3 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-35.90M	USD	3 Qtrs
COMPREHENSIVE INCOME (LOSS)	`ComprehensiveIncomeNetOfTax`	$-13.16M	USD	1 Quarter

Cash Flow Statement 52 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-13.61M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-36.12M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$56.27M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$20.34M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$27.51M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$7.28M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$3.36M	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$4.17M	USD	3 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-652.75K	USD	3 Qtrs
Amortization/(accretion) of note premiums	`InvestmentIncomeNetAmortizationOfDiscountAndPremium`	$-682.24K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$21.03M	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$1.72M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$863.29K	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$2.39M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-56.53M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$97.94M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.82M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.58M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-3.48M	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-54.22K	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$1.30M	USD	3 Qtrs
Other	`IncreaseDecreaseInOtherOperatingLiabilities`	$-538.02K	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$159.23M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-84.54M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.07M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$4.17M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$90.27M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$193.96M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$29.15M	USD	3 Qtrs
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$29.86M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-64.58M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES	`NetCashProvidedByUsedInInvestingActivities`	$-174.88M	USD	3 Qtrs
Principal payments on notes payable	`RepaymentsOfNotesPayable`	$2.42M	USD	3 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$6.44M	USD	3 Qtrs
Proceeds from the exercises of stock options	`ProceedsFromStockOptionsExercised`	$6.46M	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.50M	USD	Point-in-time
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$250.48M	USD	3 Qtrs
Proceeds from the issuance of common stock	`ProceedsFromIssuanceOfCommonStock`	$60.52M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$64.55M	USD	3 Qtrs
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES	`NetCashProvidedByUsedInFinancingActivities`	$256.94M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-2.48M	USD	3 Qtrs
NET INCREASE (DECREASE) IN CASH	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$159.20M	USD	3 Qtrs
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$30.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$219.32M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$189.33M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$30.13M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$219.32M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$189.33M	USD	Point-in-time
CASH AND CASH EQUIVALENTS AT END OF PERIOD	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$221.80M	USD	Point-in-time
Interest paid	`InterestPaidNet`	$27.44K	USD	3 Qtrs
Income Taxes Paid	`IncomeTaxesPaid`	$2.40K	USD	3 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$492.59M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$493.56M	USD	Point-in-time
Beginning Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$225.67M	USD	Point-in-time
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$27.51M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$7.28M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.96M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$10.05M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.44M	USD	3 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.13M	USD	1 Quarter
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.46M	USD	3 Qtrs
Exercise of stock options, Amount	`StockIssuedDuringPeriodValueStockOptionsExercised`	$2.77M	USD	1 Quarter
Exercise of stock options, Shares	`StockIssuedDuringPeriodSharesStockOptionsExercised`	989,197.00	shares	3 Qtrs
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$60.52M	USD	3 Qtrs
Common stock - issued for cash, Amount	`StockIssuedDuringPeriodValueNewIssues`	$250.48M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$216.41K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-81.51K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-31.17K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$453.89K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-13.61M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-36.12M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$56.27M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$20.34M	USD	1 Quarter
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$244.04M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$492.59M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$200.64M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$95.24M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$493.56M	USD	Point-in-time
Ending Balance, Amount	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$225.67M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.